“…The HepG2 cell line has been well characterized and produces most of the plasma proteins and has biosynthetic capabilities similar to those of normal human hepatocytes (Aden et al, 1979Rash et al, 1981;Tam et al, 1985). Of importance for use in in vitro cytotoxicity assays is that the HepG2 cells have retained some of the drugmetabolizing capacity of normal hepatocytes (Diamond et al, 1980;Plakunov et al, 1987;Sassa et al, 1987) which can be increased by culturing the cells in the presence of inducers, such as benzo[a]anthracene (B[a]A), 3-methylcholanthrene (3-MC), and Arochlor (Dawson et al, 1985;Bhatt, 1986;Marselos et al, 1987). Although the HepG2 cells have been used for assessments of the genotoxicity of test agents that require metabolic activation (Diamond et al, 1980;Bhatt et al, 1983;Dearfield et al, 1983Dearfield et al, , 1985Buenaventura et al, 1984;Dawson et al, 1985;Bhatt, 1986;Grady et al, 1986;Zhou et al, 1986;Eddy et al, 1987), similar applications to in vitro cytotoxicity tests have not been determined.…”